Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rusin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature|February 13, 2004
The central image of a gravitationally lensed quasarJoshua N Winn, David Rusin, Christopher S Kochanek
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|June 23, 2016
Neurocognition with maraviroc compared with tenofovir in HIVKevin R Robertson, Sachiko Miyahara, Anthony Lee, et al.
HIV Clinical Trials|June 28, 2016
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251Gregory K Robbins, Susan E Cohn, Linda J Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency VirusScott L Letendre, Huichao Chen, Ashley McKhann, et al.
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature|February 13, 2004
The central image of a gravitationally lensed quasarJoshua N Winn, David Rusin, Christopher S Kochanek
AIDS (London, England)|September 22, 2007
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infectionDavid M Margolis, A Lisa Mukherjee, Courtney V Fletcher, et al.
AIDS (London, England)|June 23, 2016
Neurocognition with maraviroc compared with tenofovir in HIVKevin R Robertson, Sachiko Miyahara, Anthony Lee, et al.
HIV Clinical Trials|June 28, 2016
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251Gregory K Robbins, Susan E Cohn, Linda J Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency VirusScott L Letendre, Huichao Chen, Ashley McKhann, et al.
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Pageof 1